With world's first automated blood pressure management system developed by KK Women's and Children's Hospital New trial results have shown that the world's first Double Intravenous Vasopressor Automated (DIVA) System affords superior ...
Tags: KKH, DIVA, Prof Sia, Blood Pressure Management
Scientists at the University of Kansas Medical Center have determined that high doses of vitamin C, administered intravenously with traditional chemotherapy, helped kill cancer cells while reducing the toxic effects of chemotherapy for some ...
Research and Markets has announced the addition of the "EMRs and Clinical Research: Current and Potential Impact" report to their offering. In this report, ISR leverages the insights and real-world experiences investigative sites have ...
Los Angeles Times: Democrat Leading In Florida Race Eyed As Test Of Obamacare A Democratic candidate who has explicitly defended Obamacare holds a slight lead in a special congressional election in Florida that both parties are eyeing as ...
Incyte Corporation (Nasdaq: INCY) announced today that it has entered into a clinical trial collaboration agreement with Merck, through a Merck subsidiary, to evaluate the safety and efficacy of Incyte's oral indoleamine dioxygenase-1 ...
Tags: collaboration agreement, Incyte's oral indoleamine dioxygenase-1, IDO1
Furiex Pharmaceuticals, Inc. (NASDAQ: FURX) today announced top-line results indicating the company's two pivotal Phase III clinical trials evaluating the efficacy and safety of eluxadoline in the treatment of diarrhea-predominant irritable ...
Tags: Furiex
Medical technology company Cogstate Limited (ASX:CGS) has today announced its technology will be used in a large paediatric clinical trial in the United States. Under the contract worth approximately US$1.4 million over four years, the ...
ResearchDx,LLC of Irvine,California,USA today announced an expansion of its operations to focus on the important Middle East clinical laboratory and diagnostics markets. As part of this initiative,ResearchDx will be exhibiting at the 2014 ...
Tags: ResearchDx, Diagnostics Organization, health
The Myelin Repair Foundation (MRF) today announced it has entered a Cooperative Research and Development Agreement (CRADA) with the National Institutes of Health (NIH) to assess MRF-008, as a potential therapeutic for multiple sclerosis ...
Tags: Multiple Sclerosis, Sclerosis, Myelin
TherapeuticsMD,Inc.(NYSE MKT:TXMD),a women's healthcare company("TherapeuticsMD"or the"Company"),announced today that it has initiated the SPRY Trial,a randomized,placebo-controlled phase 3 clinical trial designed to evaluate the safety ...
US-based ResearchDx has announced an expansion of its operations to focus on the important Middle East clinical laboratory and diagnostics markets. As part of this initiative,ResearchDx will be exhibiting at the 2014 Arab Health Congress ...
Drugs.com, the leading online clinical drug resource, and TrialReach are partnering to provide patients with information and access to treatments that are still under development. Announced today at Rock Health, this new partnership will ...
Omeros Corporation (NASDAQ: OMER) today announced positive results from a Phase 2a clinical trial of OMS824, the company's phosphodiesterase 10 (PDE10) inhibitor, in which the drug was well tolerated and demonstrated comparable systemic ...
BioClinica, a provider of clinical trial management services, announced that Mundipharma Research, a pharmaceutical research and development company, has selected BioClinica's OnPoint CTMS (clinical trial management system). With this ...
Tags: CTMS, Mundipharma Research, BioClinica, SharePoint
CEL-SCI Corporation has received approval from the Medicines and Medical Device Agency of Serbia to begin enrollment of subjects in its Phase III Head and Neck Cancer clinical trial of its investigational cancer immunotherapy treatment ...